HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 213 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q1 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,143,537 | -20.1% | 126,443 | -14.2% | 0.00% | 0.0% |
| Q2 2023 | $5,188,027 | -83.3% | 147,429 | -84.6% | 0.00% | -88.9% |
| Q1 2023 | $31,158,908 | -66.3% | 954,331 | -43.1% | 0.01% | -66.7% |
| Q4 2022 | $92,335,258 | +78.2% | 1,675,776 | +43.3% | 0.03% | +58.8% |
| Q3 2022 | $51,808,000 | +308.5% | 1,169,735 | +349.8% | 0.02% | +325.0% |
| Q2 2022 | $12,683,000 | +28.9% | 260,058 | +28.5% | 0.00% | +33.3% |
| Q1 2022 | $9,843,000 | +109.2% | 202,308 | +83.3% | 0.00% | +200.0% |
| Q4 2021 | $4,706,000 | +1200.0% | 110,361 | +1066.7% | 0.00% | – |
| Q3 2021 | $362,000 | +70.0% | 9,459 | +25.3% | 0.00% | – |
| Q2 2021 | $213,000 | – | 7,548 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Valor Management LLC | 11,218,033 | $366,268,777 | 96.46% |
| venBio Partners LLC | 1,035,396 | $33,805,679 | 18.74% |
| Nan Fung Group Holdings Ltd | 368,665 | $12,036,912 | 8.19% |
| Vivo Capital, LLC | 2,606,247 | $85,093,965 | 5.90% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 570,500 | $18,621,120 | 5.20% |
| ASHFORD CAPITAL MANAGEMENT INC | 445,418 | $14,542,898 | 2.18% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 678,715 | $22,160,045 | 2.07% |
| TANG CAPITAL MANAGEMENT LLC | 321,200 | $10,487,180 | 1.56% |
| AlphaCentric Advisors LLC | 67,500 | $2,203,875 | 1.52% |
| Paradiem, LLC | 66,995 | $2,187,387 | 0.68% |